|
EP0692971A4
(en)
|
1993-03-29 |
1997-11-12 |
Univ Cincinnati |
PEPTID YY ANALOGS AND USES THEREFOR
|
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
|
AU1159897A
(en)
|
1996-11-13 |
1998-06-03 |
University Of Cincinnati, The |
Analogs of peptide yy and uses thereof
|
|
EP0908515A3
(en)
|
1997-09-16 |
2000-04-26 |
Smithkline Beecham Plc |
Pancreatic polypeptide
|
|
US6046167A
(en)
|
1998-03-25 |
2000-04-04 |
University Of Cincinnati |
Peptide YY analogs
|
|
IL139913A0
(en)
|
1998-06-08 |
2002-02-10 |
Schering Corp |
Neuropeptide y5 receptor antagonists
|
|
US7601691B2
(en)
|
1999-05-17 |
2009-10-13 |
Conjuchem Biotechnologies Inc. |
Anti-obesity agents
|
|
CA2431800C
(en)
|
2000-12-14 |
2014-07-08 |
Amylin Pharmaceuticals, Inc. |
Peptide yy and peptide yy agonists for treatment of metabolic disorders
|
|
US6589938B2
(en)
|
2001-06-29 |
2003-07-08 |
National University Of Singapore |
Use of angiotensin I derivatives as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders
|
|
BR0212985A
(pt)
|
2001-09-24 |
2005-08-30 |
Imp College Innovations Ltd |
Uso de pyy ou de um agonista do mesmo na preparação de medicamentos para tratamento de distúrbios associados com excesso de peso
|
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
|
EP1583549A4
(en)
|
2003-01-17 |
2006-10-04 |
Sod Conseils Rech Applic |
YY PEPTIDE ANALOGS
|
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
|
CA2539253A1
(en)
|
2003-09-19 |
2005-03-31 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
JP2007537981A
(ja)
|
2003-09-19 |
2007-12-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規の血漿タンパク質親和性タグ
|
|
CN101380476A
(zh)
|
2003-09-19 |
2009-03-11 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
BRPI0417684A
(pt)
|
2003-12-18 |
2007-03-20 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
|
US8603969B2
(en)
|
2004-02-11 |
2013-12-10 |
Amylin Pharmaceuticals, Llc |
Pancreatic polypeptide family motifs and polypeptides comprising the same
|
|
BRPI0507594A
(pt)
|
2004-02-11 |
2007-07-03 |
Amylin Pharmaceuticals Inc |
polipetìdeos hìbridos com propriedades selecionáveis
|
|
ATE519495T1
(de)
|
2004-03-17 |
2011-08-15 |
7Tm Pharma As |
Y4-selektiver rezeptoragonist pp2-36 für therapeutische eingriffe
|
|
CA2559838A1
(en)
|
2004-03-17 |
2005-09-29 |
7Tm Pharma A/S |
Y2 selective receptor agonists for therapeutic interventions
|
|
CN101361967A
(zh)
|
2004-03-17 |
2009-02-11 |
7Tm制药联合股份有限公司 |
用于治疗性干预的y2/y4选择性受体激动剂
|
|
CA2560166A1
(en)
|
2004-03-17 |
2005-09-29 |
7Tm Pharma A/S |
Y2/y4 selective receptor agonists for therapeutic interventions
|
|
GB0412181D0
(en)
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
|
ES2542228T3
(es)
|
2004-07-08 |
2015-08-03 |
Novo Nordisk A/S |
Marcas de prolongación polipeptídica que comprenden un resto de tetrazol
|
|
US7994119B2
(en)
|
2004-07-19 |
2011-08-09 |
University Of Cincinnati |
Compounds for control of appetite
|
|
WO2006049681A2
(en)
|
2004-08-30 |
2006-05-11 |
Bayer Pharmaceuticals Corporation |
Selective neuropeptide y2 receptor agonists
|
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
US20090054326A1
(en)
|
2005-07-11 |
2009-02-26 |
Nastech Pharmaceutical Company Inc. |
Formulations for enhanced mucosal delivery of pyy
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
EP1934254A1
(en)
|
2005-09-21 |
2008-06-25 |
7TM Pharma A/S |
Y4 selective receptor agonists for therapeutic interventions
|
|
BRPI0520566A2
(pt)
|
2005-09-21 |
2009-05-19 |
7Tm Pharma As |
agonistas de receptores y2 seletivos para intervenções terapêuticas
|
|
WO2007065808A2
(en)
|
2005-12-07 |
2007-06-14 |
F. Hoffmann-La Roche Ag |
Neuropeptide-2 receptor-agonists
|
|
JP2009519296A
(ja)
|
2005-12-14 |
2009-05-14 |
ノボ・ノルデイスク・エー／エス |
ポリペプチド延長タグ
|
|
US20070197445A1
(en)
|
2006-01-18 |
2007-08-23 |
University Of Cincinnati |
Compounds for control of appetite
|
|
CN101432025B
(zh)
|
2006-03-21 |
2012-04-04 |
安米林药品公司 |
肽-肽酶抑制剂结合物及其使用方法
|
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
GB0621973D0
(en)
|
2006-11-03 |
2006-12-13 |
Philogen Spa |
Binding molecules and uses thereof
|
|
US20090099074A1
(en)
|
2007-01-10 |
2009-04-16 |
Conjuchem Biotechnologies Inc. |
Modulating food intake
|
|
US20100022446A1
(en)
|
2007-01-18 |
2010-01-28 |
Novo Nordisk A/S |
Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
|
|
JP2010516652A
(ja)
|
2007-01-18 |
2010-05-20 |
ノボ・ノルデイスク・エー／エス |
肥満の治療に使用される新規ペプチド
|
|
GB0708226D0
(en)
|
2007-04-27 |
2007-06-06 |
7Tm Pharma As |
Y-receptor agonists
|
|
JP2010533157A
(ja)
|
2007-07-09 |
2010-10-21 |
インペリアル イノベーションズ リミテッド |
ヒト膵臓ポリペプチド（ｈｐｐ）類似体および摂食行動に対するそれらの影響
|
|
US20100261637A1
(en)
|
2007-09-05 |
2010-10-14 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
JP2010538981A
(ja)
|
2007-09-11 |
2010-12-16 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
単独でまたはペプチドＧｌｙ−Ａｒｇ−Ｇｌｙ−Ａｓｐ−Ａｓｎ−Ｐｒｏ−ＯＨと組み合わせて用いる、治療剤としてのペプチドＨｉｓ−Ｓｅｒ−Ｌｅｕ−Ｇｌｙ−Ｌｙｓ−Ｔｒｐ−Ｌｅｕ−Ｇｌｙ−Ｈｉｓ−Ｐｒｏ−Ａｓｐ−Ｌｙｓ−Ｐｈｅの使用
|
|
WO2009042922A2
(en)
|
2007-09-27 |
2009-04-02 |
Amylin Pharmaceuticals, Inc. |
Peptide-peptidase inhibitor conjugates and methods of making and using same
|
|
RU2504550C2
(ru)
|
2008-05-16 |
2014-01-20 |
Ново Нордиск А/С |
Длительно действующие агонисты рецепторов y2 и(или) y4
|
|
US8299023B2
(en)
|
2008-09-17 |
2012-10-30 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists
|
|
GB0817067D0
(en)
|
2008-09-18 |
2008-10-22 |
7Tm Pharma As |
Intestinal treatment
|
|
CA2741921A1
(en)
|
2008-11-05 |
2010-05-14 |
F. Hoffmann-La Roche Ag |
Neuropeptide-2-receptor (y-2r) agonists and uses thereof
|
|
JP5584236B2
(ja)
|
2009-02-20 |
2014-09-03 |
イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ |
神経ペプチドｙ受容体結合化合物を有する細胞毒性コンジュゲート
|
|
EP2477643A1
(en)
*
|
2009-09-18 |
2012-07-25 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
CA2776302A1
(en)
|
2009-10-13 |
2011-04-21 |
F. Hoffmann-La Roche Ag |
Neuropeptide-2 receptor (y-2r) agonists
|
|
EP2498800A1
(en)
|
2009-11-13 |
2012-09-19 |
Novo Nordisk A/S |
Long-acting y2 receptor agonists
|
|
EP2560675A1
(en)
|
2010-04-20 |
2013-02-27 |
Novo Nordisk A/S |
Long-acting gastrin derivatives
|
|
KR101927068B1
(ko)
|
2010-05-05 |
2018-12-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
체중 감소 치료에 후속하는 dpp-4 억제제에 의한 순차적 병용 요법
|
|
GB201101459D0
(en)
|
2011-01-27 |
2011-03-16 |
Imp Innovations Ltd |
Novel compounds and thier effects on fedding behaviour
|
|
WO2013178490A1
(en)
|
2012-05-29 |
2013-12-05 |
Novo Nordisk A/S |
Pancreatic polypeptide compounds and use
|
|
UY35548A
(es)
|
2013-05-02 |
2014-11-28 |
Glaxosmithkline Ip No 2 Ltd |
Péptidos terapéuticos para el tratamiento de trastornos metabólicos.
|
|
AU2014350197B2
(en)
|
2013-11-15 |
2018-10-04 |
Novo Nordisk A/S |
Selective PYY compounds and uses thereof
|
|
AU2016275735B2
(en)
|
2015-06-12 |
2020-02-06 |
Novo Nordisk A/S |
Selective PYY compounds and uses thereof
|